Neoadjuvant chemotherapy with gemcitabine for pancreatic cancer increases in situ expression of the apoptosis marker M30 and stem cell marker CD44.
Tajima H, Ohta T, Kitagawa H, Okamoto K, Sakai S, Kinoshita J, Makino I, Furukawa H, Hayashi H, Nakamura K, Oyama K, Inokuchi M, Nakagawara H, Fujita H, Takamura H, Ninomiya I, Fushida S, Tani T, Fujimura T, Kitamura S, Ikeda H, Tsuneyama K.
Tajima H, et al. Among authors: fushida s.
Oncol Lett. 2012 Jun;3(6):1186-1190. doi: 10.3892/ol.2012.657. Epub 2012 Mar 26.
Oncol Lett. 2012.
PMID: 22783415
Free PMC article.